Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis
Joseph A. Gebbia, … , Thomas H. Bugge, Jorge L. Benach
Joseph A. Gebbia, … , Thomas H. Bugge, Jorge L. Benach
Published January 1, 1999
Citation Information: J Clin Invest. 1999;103(1):81-87. https://doi.org/10.1172/JCI5171.
View: Text | PDF
Article

The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis

  • Text
  • PDF
Abstract

The role of the plasminogen activation system (PAS) was investigated during the course of infection of a relapsing fever Borrelia species in plasminogen-deficient (plg –/–) and control (plg+/+ and plg+/–) mice. Subcutaneous inoculation of 104 spirochetes resulted in a peak spirochetemia five days after infection with 20–23 × 106 organisms per milliliter of whole blood in all mice, indicating that the PAS had no effect on the development of this phase of the infection. Anemia, thrombocytopenia, hepatitis, carditis, and splenomegaly were noted in all mice during and immediately after peak spirochetemia. Fibrin deposition in organs was noted in plg–/– mice but not in controls during these stages. Significantly greater spirochetal DNA burdens were consistently observed in the hearts and brains of control mice 28–30 days after infection, as determined by PCR amplification of this organism's flagellin gene (flaB), followed by quantitative densitometry. Furthermore, the decreased spirochetal load in brains of plg –/– mice was associated with a significant decrease in the degree of inflammation of the leptomeninges in these mice. These findings indicate a role for the PAS in heart and brain invasion by relapsing fever Borrelia, resulting in organ injury.

Authors

Joseph A. Gebbia, Juan Carlos Garcia Monco, Jay L. Degen, Thomas H. Bugge, Jorge L. Benach

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
PCR amplifications of spirochetal DNA (flaB) from blood and brains. (a) ...
PCR amplifications of spirochetal DNA (flaB) from blood and brains. (a) Representative amplifications of spirochetal DNA of blood from control (+) and plg–/– mice (–) obtained at peak, after peak, and 28–30 days after inoculation. Control and plg–/– mice (10 pair) were used to detect spirochetal DNA in hearts at 28–30 days. Control and plg–/– mice (11 pair) were used to detect spirochetal DNA in brains at 28–30 days. (b) Mean OD of the amplimers from the PCRs of the hearts of 10 pair of controls and plg–/– mice. (c) Mean OD of the amplimers from the PCRs of the brains of 11 pair of controls and plg–/– mice. For b and c, the mean OD of the uninfected PCR tissue controls was subtracted from the OD of each infected mouse.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts